Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Staber

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Gene Therapy|September 15, 2017
Long-term correction of hemophilia A mice following lentiviral mediated delivery of an optimized canine factor VIII geneJ M Staber, M J Pollpeter, C-G Anderson, et al.
The New England Journal of Medicine|September 9, 2020
BIVV001 Fusion Protein as Factor VIII Replacement Therapy for Hemophilia ABarbara A Konkle, Amy D Shapiro, Doris V Quon, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 12, 2025
Safety and Effectiveness of Emicizumab in People With Haemophilia A Enrolled in the ATHN 7 Haemophilia Natural History StudyTyler W Buckner, Shannon L Carpenter, Nabil Daoud, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 14, 2018
Recombinant factor VIII Fc fusion protein for immune tolerance induction in patients with severe haemophilia A with inhibitors-A retrospective analysisM Carcao, A Shapiro, J M Staber, et al.
American Journal of Hematology|May 19, 2020
Laboratory misdiagnosis of von Willebrand disease in post-menarchal females: A multi-center studyJulie Jaffray, Janice M Staber, Jemily Malvar, et al.
Blood|November 24, 2025
Platelet defects in patients and mice with Ehlers-Danlos syndromeMariia Kumskova, Gagan D Flora, Manasa K Nayak, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 19, 2020
Real-world data of immune tolerance induction using recombinant factor VIII Fc fusion protein in patients with severe haemophilia A with inhibitors at high risk for immune tolerance induction failure: A follow-up retrospective analysisManuel Carcao, Amy Shapiro, Nina Hwang, et al.
The New England Journal of Medicine|July 17, 2024
Efanesoctocog Alfa Prophylaxis for Children with Severe Hemophilia ALynn Malec, Flora Peyvandi, Anthony K C Chan, et al.
Blood Advances|November 24, 2020
The prospective Hemophilia Inhibitor PUP Study reveals distinct antibody signatures prior to FVIII inhibitor developmentB M Reipert, B Gangadharan, C J Hofbauer, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Gene Therapy|September 15, 2017
Long-term correction of hemophilia A mice following lentiviral mediated delivery of an optimized canine factor VIII geneJ M Staber, M J Pollpeter, C-G Anderson, et al.
The New England Journal of Medicine|September 9, 2020
BIVV001 Fusion Protein as Factor VIII Replacement Therapy for Hemophilia ABarbara A Konkle, Amy D Shapiro, Doris V Quon, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 12, 2025
Safety and Effectiveness of Emicizumab in People With Haemophilia A Enrolled in the ATHN 7 Haemophilia Natural History StudyTyler W Buckner, Shannon L Carpenter, Nabil Daoud, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 14, 2018
Recombinant factor VIII Fc fusion protein for immune tolerance induction in patients with severe haemophilia A with inhibitors-A retrospective analysisM Carcao, A Shapiro, J M Staber, et al.
American Journal of Hematology|May 19, 2020
Laboratory misdiagnosis of von Willebrand disease in post-menarchal females: A multi-center studyJulie Jaffray, Janice M Staber, Jemily Malvar, et al.
Blood|November 24, 2025
Platelet defects in patients and mice with Ehlers-Danlos syndromeMariia Kumskova, Gagan D Flora, Manasa K Nayak, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 19, 2020
Real-world data of immune tolerance induction using recombinant factor VIII Fc fusion protein in patients with severe haemophilia A with inhibitors at high risk for immune tolerance induction failure: A follow-up retrospective analysisManuel Carcao, Amy Shapiro, Nina Hwang, et al.
The New England Journal of Medicine|July 17, 2024
Efanesoctocog Alfa Prophylaxis for Children with Severe Hemophilia ALynn Malec, Flora Peyvandi, Anthony K C Chan, et al.
Blood Advances|November 24, 2020
The prospective Hemophilia Inhibitor PUP Study reveals distinct antibody signatures prior to FVIII inhibitor developmentB M Reipert, B Gangadharan, C J Hofbauer, et al.
Pageof 3